File:Monoclonal Antibodies3.jpg
Public domain image from cancer.gov http://visualsonline.cancer.gov/details.cfm?imageid=2008. Pictured are two researchers looking at slides of cultures of cells that make monoclonal antibodies. These are grown in a lab and the researchers are analyzing the products to select the most promising of them.
In addition to the implicit public domain status provided as a work of the United States Government, the en:National Cancer Institute has also explicitly licensed this photo into the public domain: http://visualsonline.cancer.gov/about.cfm
Date
Source
The National Cancer Institute's (NCI) Visuals Online
Author
Linda Bartlett (Photographer)
Permission
(Reusing this file)
This image is in the public domain and can be freely reused. Please credit the source and/or author listed above.
(Reusing this file)
Licensing
|
This work is in the public domain in the United States because it is a work prepared by an officer or employee of the United States Government as part of that person’s official duties under the terms of Title 17, Chapter 1, Section 105 of the US Code.
Note: This only applies to original works of the Federal Government and not to the work of any individual U.S. state, territory, commonwealth, county, municipality, or any other subdivision. This template also does not apply to postage stamp designs published by the United States Postal Service since 1978. (See § 313.6(C)(1) of Compendium of U.S. Copyright Office Practices). It also does not apply to certain US coins; see The US Mint Terms of Use.
|
 |
| This file has been identified as being free of known restrictions under copyright law, including all related and neighboring rights. | ||
Original upload log
The original description page was here. All following user names refer to en.wikipedia.
- 2006-09-02 23:19 Quintote 1350×900×8 (692655 bytes) Public domain image from cancer.gov. Pictured are two researchers looking at slides of cultures of cells that make monoclonal antibodies. These are grown in a lab and the researchers are analyzing the products to select the most promising of them.
